Genprex, Inc. (GNPX) SEC Filings & Financial Intelligence
Genprex, Inc. (GNPX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GNPX
CIK: 1595248
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: TX
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerKurt Simmons
Audit LocationEast Brunswick, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-18 | 2026-08-18 | FORM 8-K | 0001437749-26-028250 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001437749-26-027846 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-04 | FORM 8-K | 0001437749-26-025938 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001437749-26-025302 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | FORM 8-K | 0001437749-26-025074 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-13 | FORM 8-K | 0001437749-26-023480 | View SEC Doc Filr Page |
| S-8 | 2026-06-26 | — | FORM S-8 | 0001437749-26-021854 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-22 | FORM 8-K | 0001437749-26-021262 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | FORM 8-K | 0001437749-26-021134 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | FORM 8-K | 0001437749-26-020501 | View SEC Doc Filr Page |
| S-3 | 2026-06-05 | — | FORM S-3 | 0001437749-26-019760 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | FORM 8-K | 0001437749-26-018318 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | FORM 8-K | 0001437749-26-016883 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001437749-26-016755 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022311 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | FORM 8-K | 0001437749-26-013989 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | FORM ARS | 0001437749-26-013907 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-18 | FORM DEF 14A | 0001437749-26-013906 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-28 | FORM 8-K | 0001437749-26-013534 | View SEC Doc Filr Page |
| 8-K | 2026-04-21 | 2026-04-21 | FORM 8-K | 0001437749-26-012879 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-17 | 2026-06-18 | FORM PRE 14A | 0001437749-26-012694 | View SEC Doc Filr Page |
| 4 | 2026-04-15 | 2026-04-14 | FORM 4 | 0001437749-26-012463 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | FORM 10-K | 0001437749-26-010346 | View SEC Doc Filr Page |
| 8-K | 2026-03-18 | 2026-03-18 | FORM 8-K | 0001437749-26-008733 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-27 | FORM 4 | 0001437749-26-006154 | View SEC Doc Filr Page |